866-997-4948(US-Canada Toll Free)

Optic Nerve Disorders Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Published By :

Transparency Market Research

Published Date : Jan 2020

Category :

Healthcare

No. of Pages : 211 Pages

Optic Nerve Disorders Treatment Market – Scope of the Report

TMR’s report on the global optic nerve disorders treatment market studies the past as well as current growth trends and opportunities to gain valuable insights of the indicators for the said market during the forecast period from 2019 to 2027. The report provides the overall market revenue of the optic nerve disorders treatment market for the 2017–2027 period, with 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the optic nerve disorders treatment market for the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involves bulk of research efforts, wherein analysts carry out interviews with key opinion leaders, industry leaders, and opinion makers. Extensive secondary research involves referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the optic nerve disorders treatment market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of top-down and bottom-up approach to study various phenomena in the optic nerve disorders treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Furthermore, the report sheds light on changing competitive dynamics in the optic nerve disorders treatment market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the optic nerve disorders treatment market.

The report delves into the competitive landscape of the optic nerve disorders treatment market. Key players operating in the optic nerve disorders treatment market have been identified, and each one of them has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the optic nerve disorders treatment market that have been profiled in this report.

Key Questions Answered in Optic Nerve Disorders Treatment Market Report

  • What are the sales/revenue generated by each treatment type segment of the optic nerve disorders treatment market across all regions during the forecast period?
  • What are the opportunities in the optic nerve disorders treatment market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which region is likely to expand at the fastest CAGR during the forecast period?
  • Which optic nerve disorders treatment type, indication, and end user segments are expected to generate the maximum revenue globally in 2027? Which segment is projected to expand at the highest CAGR during the forecast period?
  • What was the market share or position of different companies operating in the global market in 2018?

Optic Nerve Disorders Treatment Market – Research Objectives and Research Approach

The comprehensive report on the optic nerve disorders treatment market begins with an overview of the said market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study, pipeline analysis, key vendor & distributor analysis, regulatory scenario, technological advancements, and disease prevalence rate of different optic nerve disorders.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into small sections. The entire report comprises an exhaustive collection of graphs and tables appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the optic nerve disorders treatment market in terms of treatment type, indication, end user, and region. Key segments under each criteria have been studied at length, and the market share for each of them at the end of 2027 has been provided herein. Such valuable insights enable market stakeholders in making informed business decisions for investment in the optic nerve disorders treatment market.

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Optic Nerve Disorders Treatment Market

4. Market Overview

4.1. Introduction

4.1.1. Treatment Type Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Optic Nerve Disorders Treatment Market Analysis and Forecasts, 2017–2027

4.4.1. Market Revenue Projections (US$ Mn)

5. Market Outlook

5.1. Pipeline Analysis

5.2. Key Vendor and Distributor Analysis

5.3. Technological Advancements

5.4. Prevalence & Incidence of Optic Nerve Disorders

5.5. Regulatory Scenario Assessment

6. Global Optic Nerve Disorders Treatment Market Analysis and Forecasts, By Treatment Type 

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Market Value Forecast By Treatment Type, 2017–2027

6.3.1. Pharmacological Treatment

6.3.1.1. Prostaglandins

6.3.1.2. Beta Interferons

6.3.1.3. Beta Blockers

6.3.1.4. Alpha-adrenergic Agonist

6.3.1.5. Carbonic Anhydrase Inhibitors

6.3.1.6. Corticosteroids

6.3.1.7. Combination Drugs

6.3.1.8. Others

6.3.2. Surgery

6.4. Market Attractiveness By Treatment Type, 2019-2027

7. Global Optic Nerve Disorders Treatment Market Analysis and Forecasts, By Indication 

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Market Value Forecast By Indication, 2017–2027

7.3.1. Glaucoma

7.3.2. Optic Neuritis

7.3.3. Optic Neuropathy

7.3.3.1. Arteritic ischemic optic neuropathy

7.3.3.2. Non-arteritic ischemic optic neuropathy

7.3.3.3. Congenital Optic Atrophy

7.3.4. Others

7.4. Market Attractiveness By Indication, 2019-2027

8. Global Optic Nerve Disorders Treatment Market Analysis and Forecasts, By End-user 

8.1. Introduction & Definition

8.2. Key Findings / Developments

8.3. Market Value Forecast By End-user, 2017–2027

8.3.1. Hospitals

8.3.2. Ambulatory Surgery Centers

8.3.3. Clinics

8.3.4. Others

8.4. Market Attractiveness By End-user, 2019-2027

9. Global Optic Nerve Disorders Treatment Market Analysis and Forecasts, By Region

9.1. Key Findings

9.2. Market Value Forecast By Region

9.2.1. North America 

9.2.2. Europe 

9.2.3. Asia Pacific 

9.2.4. Latin America 

9.2.5. Middle East & Africa 

9.3. Market Attractiveness By Country/Region, 2019-2027

10. North America Optic Nerve Disorders Treatment Market Analysis and Forecast

10.1. Introduction

10.1.1. Key Findings

10.2. Market Value Forecast By Treatment Type, 2017–2027

10.2.1. Pharmacological Treatment

10.2.1.1. Prostaglandins

10.2.1.2. Beta Interferons

10.2.1.3. Beta Blockers

10.2.1.4. Alpha-adrenergic Agonist

10.2.1.5. Carbonic Anhydrase Inhibitors

10.2.1.6. Corticosteroids

10.2.1.7. Combination Drugs

10.2.1.8. Others

10.2.2. Surgery

10.3. Market Value Forecast By Indication, 2017–2027

10.3.1. Glaucoma

10.3.2. Optic Neuritis

10.3.3. Optic Neuropathy

10.3.3.1. Arteritic ischemic optic neuropathy

10.3.3.2. Non-arteritic ischemic optic neuropathy

10.3.3.3. Congenital Optic Atrophy

10.3.4. Others

10.4. Market Value Forecast By End-user, 2017–2027

10.4.1. Hospitals

10.4.2. Ambulatory Surgery Centers

10.4.3. Clinics

10.4.4. Others

10.5. Market Value Forecast By Country, 2017–2027

10.5.1. U.S.

10.5.2. Canada

10.6. Market Attractiveness Analysis 

10.6.1. By Treatment Type 

10.6.2. By Indication 

10.6.3. By End-user 

10.6.4. By Country

11. Europe Optic Nerve Disorders Treatment Market Analysis and Forecast

11.1. Introduction

11.1.1. Key Findings

11.2. Market Value Forecast by Treatment Type, 2017–2027

11.2.1. Pharmacological Treatment

11.2.1.1. Prostaglandins

11.2.1.2. Beta Interferons

11.2.1.3. Beta Blockers

11.2.1.4. Alpha-adrenergic Agonist

11.2.1.5. Carbonic Anhydrase Inhibitors

11.2.1.6. Corticosteroids

11.2.1.7. Combination Drugs

11.2.1.8. Others

11.2.2. Surgery

11.3. Market Value Forecast by Indication, 2017–2027

11.3.1. Glaucoma

11.3.2. Optic Neuritis

11.3.3. Optic Neuropathy

11.3.3.1. Arteritic ischemic optic neuropathy

11.3.3.2. Non-arteritic ischemic optic neuropathy

11.3.3.3. Congenital Optic Atrophy

11.3.4. Others

11.4. Market Value Forecast by End-user, 2017–2027

11.4.1. Hospitals

11.4.2. Ambulatory Surgery Centers

11.4.3. Clinics

11.4.4. Others

11.5. Market Value Forecast by Country/Sub-region, 2017–2027

11.5.1. Germany

11.5.2. U.K.

11.5.3. France

11.5.4. Spain

11.5.5. Italy

11.5.6. Rest of Europe

11.6. Market Attractiveness Analysis 

11.6.1. By Treatment Type 

11.6.2. By Indication 

11.6.3. By End-user 

11.6.4. By Country

12. Asia Pacific Optic Nerve Disorders Treatment Market Analysis and Forecast

12.1. Introduction

12.1.1. Key Findings

12.2. Market Value Forecast by Treatment Type, 2017–2027

12.2.1. Pharmacological Treatment

12.2.1.1. Prostaglandins

12.2.1.2. Beta Interferons

12.2.1.3. Beta Blockers

12.2.1.4. Alpha-adrenergic Agonist

12.2.1.5. Carbonic Anhydrase Inhibitors

12.2.1.6. Corticosteroids

12.2.1.7. Combination Drugs

12.2.1.8. Others

12.2.2. Surgery

12.3. Market Value Forecast by Indication, 2017–2027

12.3.1. Glaucoma

12.3.2. Optic Neuritis

12.3.3. Optic Neuropathy

12.3.3.1. Arteritic ischemic optic neuropathy

12.3.3.2. Non-arteritic ischemic optic neuropathy

12.3.3.3. Congenital Optic Atrophy

12.3.4. Others

12.4. Market Value Forecast by End-user, 2017–2027

12.4.1. Hospitals

12.4.2. Ambulatory Surgery Centers

12.4.3. Clinics

12.4.4. Others

12.5. Market Value Forecast by Country/Sub-region, 2017–2027

12.5.1. China

12.5.2. Japan

12.5.3. India

12.5.4. Australia & New Zealand

12.5.5. Rest of Asia Pacific

12.6. Market Attractiveness Analysis 

12.6.1. By Treatment Type 

12.6.2. By Indication 

12.6.3. By End-user 

12.6.4. By Country

13. Latin America Optic Nerve Disorders Treatment Market Analysis and Forecast

13.1. Introduction

13.1.1. Key Findings

13.2. Market Value Forecast by Treatment Type, 2017–2027

13.2.1. Pharmacological Treatment

13.2.1.1. Prostaglandins

13.2.1.2. Beta Interferons

13.2.1.3. Beta Blockers

13.2.1.4. Alpha-adrenergic Agonist

13.2.1.5. Carbonic Anhydrase Inhibitors

13.2.1.6. Corticosteroids

13.2.1.7. Combination Drugs

13.2.1.8. Others

13.2.2. Surgery

13.3. Market Value Forecast by Indication, 2017–2027

13.3.1. Glaucoma

13.3.2. Optic Neuritis

13.3.3. Optic Neuropathy

13.3.3.1. Arteritic ischemic optic neuropathy

13.3.3.2. Non-arteritic ischemic optic neuropathy

13.3.3.3. Congenital Optic Atrophy

13.3.4. Others

13.4. Market Value Forecast by End-user, 2017–2027

13.4.1. Hospitals

13.4.2. Ambulatory Surgery Centers

13.4.3. Clinics

13.4.4. Others

13.5. Market Value Forecast By Country/Sub-region, 2017–2027

13.5.1. Brazil

13.5.2. Mexico

13.5.3. Rest of Latin America

13.6. Market Attractiveness Analysis 

13.6.1. By Treatment Type 

13.6.2. By Indication 

13.6.3. By End-user 

13.6.4. By Country

14. Middle East & Africa Optic Nerve Disorders Treatment Market Analysis and Forecast

14.1. Introduction

14.1.1. Key Findings

14.2. Market Value Forecast by Treatment Type, 2017–2027

14.2.1. Pharmacological Treatment

14.2.1.1. Prostaglandins

14.2.1.2. Beta Interferons

14.2.1.3. Beta Blockers

14.2.1.4. Alpha-adrenergic Agonist

14.2.1.5. Carbonic Anhydrase Inhibitors

14.2.1.6. Corticosteroids

14.2.1.7. Combination Drugs

14.2.1.8. Others

14.2.2. Surgery

14.3. Market Value Forecast by Indication, 2017–2027

14.3.1. Glaucoma

14.3.2. Optic Neuritis

14.3.3. Optic Neuropathy

14.3.3.1. Arteritic ischemic optic neuropathy

14.3.3.2. Non-arteritic ischemic optic neuropathy

14.3.3.3. Congenital Optic Atrophy

14.3.4. Others

14.4. Market Value Forecast by End-user, 2017–2027

14.4.1. Hospitals

14.4.2. Ambulatory Surgery Centers

14.4.3. Clinics

14.4.4. Others

14.5. Market Value Forecast by Country/Sub-region, 2017–2027

14.5.1. GCC Countries

14.5.2. South Africa

14.5.3. Rest of Middle East & Africa

14.6. Market Attractiveness Analysis 

14.6.1. By Treatment Type 

14.6.2. By Indication 

14.6.3. By End-user 

14.6.4. By Country

15. Competition Landscape

15.1. Market Player – Competition Matrix (By Tier and Size of companies)

15.2. Market Position/Ranking Analysis, By Tier and Size of the Company (2018)

15.3. Company Profiles

15.3.1. Santen Pharmaceutical Co., Ltd.

15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.1.2. Company Financials

15.3.1.3. Growth Strategies

15.3.1.4. SWOT Analysis

15.3.2. Allergan plc.

15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.2.2. Company Financials

15.3.2.3. Growth Strategies

15.3.2.4. SWOT Analysis

15.3.3. Novartis AG

15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.3.2. Company Financials

15.3.3.3. Growth Strategies

15.3.3.4. SWOT Analysis

15.3.4. Pfizer, Inc.

15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.4.2. Company Financials

15.3.4.3. Growth Strategies

15.3.4.4. SWOT Analysis

15.3.5. Bausch Health Companies, Inc.

15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.5.2. Company Financials

15.3.5.3. Growth Strategies

15.3.5.4. SWOT Analysis

15.3.6. Aerie Pharmaceuticals, Inc.

15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.6.2. Company Financials

15.3.6.3. Growth Strategies

15.3.6.4. SWOT Analysis

15.3.7. Teva Pharmaceutical Industries Ltd.

15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.7.2. Company Financials

15.3.7.3. Growth Strategies

15.3.7.4. SWOT Analysis

15.3.8. Bionure Farma, S.L.

15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.8.2. Company Financials

15.3.8.3. Growth Strategies

15.3.8.4. SWOT Analysis

15.3.9. Mallinckrodt Pharmaceuticals

15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.9.2. Company Financials

15.3.9.3. Growth Strategies

15.3.9.4. SWOT Analysis

List of Table

List of Tables

Table 01: Global Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027 

Table 02: Global Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast, by Pharmacological Treatment, 2017–2027 

Table 03: Global Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2017–2027 

Table 04: Global Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast, by Optic Neuropathy, 2017–2027 

Table 05: Global Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2027 

Table 06: Global Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2027 

Table 07: North America Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast, by Country, 2017–2027 

Table 08: North America Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027 

Table 09: North America Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast, by Pharmacological Treatment, 2017–2027 

Table 10: North America Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2017–2027 

Table 11: North America Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast, by Optic Neuropathy, 2017–2027 

Table 12: North America Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2027 

Table 13: Europe Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027 

Table 14: Europe Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027 

Table 15: Europe Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast, by Pharmacological Treatment, 2017–2027 

Table 16: Europe Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2017–2027 

Table 17: Europe Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast, by Optic Neuropathy, 2017–2027 

Table 18: Europe Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2027 

Table 19: Asia Pacific Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027 

Table 20: Asia Pacific Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027 

Table 21: Asia Pacific Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast, by Pharmacological Treatment, 2017–2027 

Table 22: Asia Pacific Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2017–2027 

Table 23: Asia Pacific Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast, by Optic Neuropathy, 2017–2027 

Table 24: Asia Pacific Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2027 

Table 25: Latin America Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027 

Table 26: Latin America Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027 

Table 27: Latin America Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast, by Pharmacological Treatment, 2017–2027 

Table 28: Latin America Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2017–2027 

Table 29: Latin America Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast, by Optic Neuropathy, 2017–2027 

Table 30: Latin America Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2027 

Table 31: Middle East & Africa Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027 

Table 32: Middle East & Africa Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027 

Table 33: Middle East & Africa Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast, by Pharmacological Treatment, 2017–2027 

Table 34: Middle East & Africa Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2017–2027 

Table 35: Middle East & Africa Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast, by Optic Neuropathy, 2017–2027 

Table 36: Middle East & Africa Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2027

List of Chart

List of Figures

Figure 01: Global Optic Nerve Disorders Treatment Market Size (US$ Mn) and Distribution, by Region, 2018 and 2027

Figure 02: Global Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast, 2017–2027

Figure 03: Global Optic Nerve Disorders Treatment Market Value Share, by Treatment Type (2018)

Figure 04: Global Optic Nerve Disorders Treatment Market Value Share, by Pharmacological Treatment (2018)

Figure 05: Global Optic Nerve Disorders Treatment Market Value Share, by Indication (2018)

Figure 06: Global Optic Nerve Disorders Treatment Market Value Share, by End-user (2018)

Figure 07: Global Optic Nerve Disorders Treatment Market Value Share, by Region (2018)

Figure 08: Regulatory Approval Process - The U.S.  

Figure 09: Regulatory Approval Process - Europe 

Figure 10: Global Optic Nerve Disorders Treatment Market Value Share Analysis, by Treatment Type, 2018 and 2027

Figure 11: Global Optic Nerve Disorders Treatment Market Value Share Analysis, by Pharmacological Treatment, 2018 and 2027

Figure 12: Global Optic Nerve Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Pharmacological Treatment, 2017–2027

Figure 13: Global Optic Nerve Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Surgery, 2017–2027

Figure 14: Global Optic Nerve Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Prostaglandins, 2017-2027

Figure 15: Global Optic Nerve Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Beta Interferons, 2017-2027

Figure 16: Global Optic Nerve Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Beta Blockers, 2017-2027

Figure 17: Global Optic Nerve Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Alpha-adrenergic agonist, 2017-2027

Figure 18: Global Optic Nerve Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Carbonic Anhydrase Inhibitors, 2017-2027

Figure 19: Global Optic Nerve Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Corticosteroidss, 2017-2027

Figure 20: Global Optic Nerve Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Combination Drugs, 2017-2027

Figure 21: Global Optic Nerve Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2027

Figure 22: Global Optic Nerve Disorders Treatment Market Attractiveness, by Treatment Type, 2019–2027

Figure 23: Global Optic Nerve Disorders Treatment Market Value Share Analysis, by Indication, 2018 and 2027

Figure 24: Global Optic Nerve Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Glaucoma, 2017-2027

Figure 25: Global Optic Nerve Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Optic Neuritis, 2017-2027

Figure 26: Global Optic Nerve Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Optic Neuropathy, 2017-2027

Figure 27: Global Optic Nerve Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2027

Figure 28: Global Optic Nerve Disorders Treatment Market Attractiveness, by Indication, 2019–2027

Figure 29: Global Optic Nerve Disorders Treatment Market Value Share Analysis, by End-user, 2018 and 2027

Figure 30: Global Optic Nerve Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017–2027

Figure 31: Global Optic Nerve Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Ambulatory Surgery Centers, 2017–2027

Figure 32: Global Optic Nerve Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Clinics, 2017–2027

Figure 33: Global Optic Nerve Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Academic & Research Institutes, 2017–2027

Figure 34: Global Optic Nerve Disorders Treatment Market Attractiveness, by End-user, 2019–2027

Figure 35: Global Optic Nerve Disorders Treatment Market Value Share, by Region, 2018 and 2027

Figure 36: Global Optic Nerve Disorders Treatment Market Attractiveness, by Region, 2019–2027

Figure 37: North America Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 38: North America Optic Nerve Disorders Treatment Market Value Share, by Country, 2018 and 2027

Figure 39: North America Optic Nerve Disorders Treatment Market Attractiveness, by Country, 2019–2027

Figure 40: North America Optic Nerve Disorders Treatment Market Value Share, by Treatment Type, 2018 and 2027

Figure 41: North America Optic Nerve Disorders Treatment Market Value Share, by Pharmacological Treatment, 2018 and 2027

Figure 42: North America Optic Nerve Disorders Treatment Market Attractiveness, by Treatment type, 2019–2027

Figure 43: North America Optic Nerve Disorders Treatment Market Value Share, by Indication, 2018 and 2027

Figure 44: North America Optic Nerve Disorders Treatment Market Attractiveness, by Indication, 2019–2027 

Figure 45: North America Optic Nerve Disorders Treatment Market Value Share, by End-user, 2018 and 2027 

Figure 46: North America Optic Nerve Disorders Treatment Market Attractiveness, by End-user, 2019–2027 

Figure 47: Europe Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 48: Europe Optic Nerve Disorders Treatment Market Value Share, by Country/Sub-region, 2018 and 2027 

Figure 49: Europe Optic Nerve Disorders Treatment Market Attractiveness, by Country/Sub-region, 2019–2027 

Figure 50: Europe Optic Nerve Disorders Treatment Market Value Share, by Treatment Type, 2018 and 2027

Figure 51: Europe Optic Nerve Disorders Treatment Market Value Share, by Pharmacological Treatment, 2018 and 2027

Figure 52: Europe Optic Nerve Disorders Treatment Market Attractiveness, by Treatment type, 2019–2027

Figure 53: Europe Optic Nerve Disorders Treatment Market Value Share, by Indication, 2018 and 2027

Figure 54: Europe Optic Nerve Disorders Treatment Market Attractiveness, by Indication, 2019–2027 

Figure 55: Europe Optic Nerve Disorders Treatment Market Value Share, by End-user, 2018 and 2027 

Figure 56: Europe Optic Nerve Disorders Treatment Market Attractiveness, by End-user, 2019–2027 

Figure 57: Asia Pacific Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 58: Asia Pacific Optic Nerve Disorders Treatment Market Value Share, by Country/Sub-region, 2018 and 2027 

Figure 59: Asia Pacific Optic Nerve Disorders Treatment Market Attractiveness, by Country/Sub-region, 2019–2027 

Figure 60: Asia Pacific Optic Nerve Disorders Treatment Market Value Share, by Treatment Type, 2018 and 2027

Figure 61: Asia Pacific Optic Nerve Disorders Treatment Market Value Share, by Pharmacological Treatment, 2018 and 2027

Figure 62: Asia Pacific Optic Nerve Disorders Treatment Market Attractiveness, by Treatment type, 2019–2027

Figure 63: Asia Pacific Optic Nerve Disorders Treatment Market Value Share, by Indication, 2018 and 2027

Figure 64: Asia Pacific Optic Nerve Disorders Treatment Market Attractiveness, by Indication, 2019–2027 

Figure 65: Asia Pacific Optic Nerve Disorders Treatment Market Value Share, by End-user, 2018 and 2027 

Figure 66: Asia Pacific Optic Nerve Disorders Treatment Market Attractiveness, by End-user, 2019–2027 

Figure 67: Latin America Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 68: Latin America Optic Nerve Disorders Treatment Market Value Share, by Country/Sub-region, 2018 and 2027 

Figure 69: Latin America Optic Nerve Disorders Treatment Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 70: Latin America Optic Nerve Disorders Treatment Market Value Share, by Treatment Type, 2018 and 2027

Figure 71: Latin America Optic Nerve Disorders Treatment Market Value Share, by Pharmacological Treatment, 2018 and 2027

Figure 72: Latin America Optic Nerve Disorders Treatment Market Attractiveness, by Treatment Type, 2019–2027

Figure 73: Latin America Optic Nerve Disorders Treatment Market Value Share, by Indication, 2018 and 2027

Figure 74: Latin America Optic Nerve Disorders Treatment Market Attractiveness, by Indication, 2019–2027 

Figure 75: Latin America Optic Nerve Disorders Treatment Market Value Share, by End-user, 2018 and 2027 

Figure 76: Latin America Optic Nerve Disorders Treatment Market Attractiveness, by End-user, 2019–2027 

Figure 77: Middle East & Africa Optic Nerve Disorders Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 78: Middle East & Africa Optic Nerve Disorders Treatment Market Value Share, by Country/Sub-region, 2018 and 2027 

Figure 79: Middle East & Africa Optic Nerve Disorders Treatment Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 80: Middle East & Africa Optic Nerve Disorders Treatment Market Value Share, by Treatment Type, 2018 and 2027

Figure 81: Middle East & Africa Optic Nerve Disorders Treatment Market Value Share, by Pharmacological Treatment, 2018 and 2027

Figure 82: Middle East & Africa Optic Nerve Disorders Treatment Market Attractiveness, by Treatment Type, 2019–2027

Figure 83: Middle East & Africa Optic Nerve Disorders Treatment Market Value Share, by Indication, 2018 and 2027

Figure 84: Middle East & Africa Optic Nerve Disorders Treatment Market Attractiveness, by Indication, 2019–2027 

Figure 85: Middle East & Africa Optic Nerve Disorders Treatment Market Value Share, by End-user, 2018 and 2027 

Figure 86: Middle East & Africa Optic Nerve Disorders Treatment Market Attractiveness, by End-user, 2019–2027 

Figure 87: Market Position/Ranking Analysis, 2018, by Tier and Size of the Company

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *